Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Development and validation of a questionnaire evaluating the impact of hepatitis B immune globulin prophylaxis on the quality of life of liver transplant recipients.

Franciosi M, Caccamo L, De Simone P, Pinna AD, Di Costanzo GG, Volpes R, Scuderi V, Strignano P, Boccagni P, Burra P, Nicolucci A; TWINS I Study Group.

Liver Transpl. 2012 Mar;18(3):332-9. doi: 10.1002/lt.22473.

2.

Antibody to hepatitis B surface antigen trough levels and half-lives do not differ after intravenous and intramuscular hepatitis B immunoglobulin administration after liver transplantation.

Hooman N, Rifai K, Hadem J, Vaske B, Philipp G, Priess A, Klempnauer J, Tillmann HL, Manns MP, Rosenau J.

Liver Transpl. 2008 Apr;14(4):435-42. doi: 10.1002/lt.21343.

3.

Intramuscular hepatitis B immunoglobulin (HBIG) and nucleosides for prevention of recurrent hepatitis B following liver transplantation: comparison with other HBIG regimens.

Anderson RD, Chinnakotla S, Guo L, Perrillo RP, Klintmalm GB, Davis GL.

Clin Transplant. 2007 Jul-Aug;21(4):510-7.

PMID:
17645711
4.
5.

Pharmacokinetics and efficacy of intravenous or intramuscular hepatitis B immunoglobulins in prophylaxis of hepatitis B after liver transplantation.

Marzano A, Marengo A, Andreone P, Volpes R, Canova D, Cursaro C, Riili A, Fiorentino B, Bacci M, Guazzini S, Burra P.

Minerva Med. 2010 Dec;101(6):373-83.

PMID:
21196896
6.

Intramuscular hepatitis B immune globulin combined with lamivudine for prophylaxis against hepatitis B recurrence after liver transplantation.

Yao FY, Osorio RW, Roberts JP, Poordad FF, Briceno MN, Garcia-Kennedy R, Gish RR.

Liver Transpl Surg. 1999 Nov;5(6):491-6.

7.

Escape hepatitis B virus mutations in recipients of antibody to hepatitis B core antigen-positive liver grafts receiving hepatitis B immunoglobulins.

Roche B, Roque-Afonso AM, Sebagh M, Delvart V, Duclos-Vallee JC, Castaing D, Samuel D.

Liver Transpl. 2010 Jul;16(7):885-94. doi: 10.1002/lt.22084.

8.

Failure of hepatitis B vaccination with conventional HBsAg vaccine in patients with continuous HBIG prophylaxis after liver transplantation.

Rosenau J, Hooman N, Hadem J, Rifai K, Bahr MJ, Philipp G, Tillmann HL, Klempnauer J, Strassburg CP, Manns MP.

Liver Transpl. 2007 Mar;13(3):367-73.

9.

Efficacy of maintenance subcutaneous hepatitis B immune globulin (HBIG) post-transplant for prophylaxis against hepatitis B recurrence.

Singham J, Greanya ED, Lau K, Erb SR, Partovi N, Yoshida EM.

Ann Hepatol. 2010 Apr-Jun;9(2):166-71.

PMID:
20526010
10.

Low-dose hepatitis B immune globulin and higher-dose lamivudine combination to prevent hepatitis B virus recurrence after liver transplantation.

Karasu Z, Ozacar T, Akyildiz M, Demirbas T, Arikan C, Kobat A, Akarca U, Ersoz G, Gunsar F, Batur Y, Kilic M, Tokat Y.

Antivir Ther. 2004 Dec;9(6):921-7.

PMID:
15651751
11.

Evolving experience of hepatitis B virus prophylaxis in liver transplantation.

Honaker MR, Shokouh-Amiri MH, Vera SR, Alloway RR, Grewal HP, Hardinger KL, Kizilisik AT, Bagous T, Trofe J, Stratta RJ, Egidi MF, Gaber AO.

Transpl Infect Dis. 2002 Sep;4(3):137-43.

PMID:
12421458
12.

Hepatitis B prophylaxis in living donor liver transplantation: single center experience.

Yaprak O, Dayangac M, Balci D, Bas K, Yuzer Y, Tokat Y.

Hepatogastroenterology. 2010 Sep-Oct;57(102-103):1178-82.

PMID:
21410054
13.

Safety and efficacy of subcutaneous hepatitis B immunoglobulin after liver transplantation: an open single-arm prospective study.

Di Costanzo GG, Lanza AG, Picciotto FP, Imparato M, Migliaccio C, De Luca M, Scuderi V, Tortora R, Cordone G, Utech W, Calise F.

Am J Transplant. 2013 Feb;13(2):348-52. doi: 10.1111/j.1600-6143.2012.04319.x. Epub 2012 Nov 8.

14.
15.

A randomized study of adefovir dipivoxil in place of HBIG in combination with lamivudine as post-liver transplantation hepatitis B prophylaxis.

Angus PW, Patterson SJ, Strasser SI, McCaughan GW, Gane E.

Hepatology. 2008 Nov;48(5):1460-6. doi: 10.1002/hep.22524.

PMID:
18925641
16.

Subcutaneous administration of hepatitis B immune globulin in combination with lamivudine following orthotopic liver transplantation: effective prophylaxis against recurrence.

Powell JJ, Apiratpracha W, Partovi N, Erb SR, Scudamore CH, Steinbrecher UP, Buczkowski AK, Chung SW, Yoshida EM.

Clin Transplant. 2006 Jul-Aug;20(4):524-5.

PMID:
16842532
18.

An efficacy and cost-effectiveness analysis of combination hepatitis B immune globulin and lamivudine to prevent recurrent hepatitis B after orthotopic liver transplantation compared with hepatitis B immune globulin monotherapy.

Han SH, Ofman J, Holt C, King K, Kunder G, Chen P, Dawson S, Goldstein L, Yersiz H, Farmer DG, Ghobrial RM, Busuttil RW, Martin P.

Liver Transpl. 2000 Nov;6(6):741-8.

19.

Hepatitis B immunoglobulin and/or nucleos(t)ide analogues for prophylaxis against hepatitis b virus recurrence after liver transplantation: a systematic review.

Cholongitas E, Goulis J, Akriviadis E, Papatheodoridis GV.

Liver Transpl. 2011 Oct;17(10):1176-90. doi: 10.1002/lt.22354. Review.

Supplemental Content

Support Center